Kawasaki Disease and Respiratory Viruses: Ecological Spatiotemporal Analysis.

Kawasaki disease RSV children community epidemiology human metapneumovirus infection pediatric respiratory disease respiratory diseases respiratory syncytial virus respiratory virus viral infection virology

Journal

JMIR public health and surveillance
ISSN: 2369-2960
Titre abrégé: JMIR Public Health Surveill
Pays: Canada
ID NLM: 101669345

Informations de publication

Date de publication:
25 Jul 2024
Historique:
received: 04 06 2023
revised: 11 02 2024
accepted: 05 04 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 26 7 2024
Statut: epublish

Résumé

Kawasaki disease is an uncommon vasculitis affecting young children. Its etiology is not completely understood, although infections have been frequently postulated as the triggers. Respiratory viruses, specifically, have often been implicated as causative agents for Kawasaki disease presentations. We aimed to conduct an ecological spatiotemporal analysis to determine whether Kawasaki disease incidence was related to community respiratory virus circulation in a shared region and population, and to describe viral associations before and during the COVID-19 pandemic. We obtained independent statewide data sets of hospital admissions of Kawasaki disease and respiratory multiplex polymerase chain reaction tests performed at two large hospital networks in Victoria, Australia, from July 2011 to November 2021. We studied spatiotemporal relationships by negative binomial regression analysis of the monthly incidence of Kawasaki disease and the rate of positive respiratory polymerase chain reaction tests in different regions of Victoria. Peak viral seasons (95th percentile incidence) were compared to median viral circulation (50th percentile incidence) to calculate peak season increased rate ratios. While no seasonal trend in Kawasaki disease incidence was identified throughout the study period, we found a 1.52 (99% CI 1.27-1.82) and a 1.43 (99% CI 1.17-1.73) increased rate ratio of Kawasaki disease presentations in association with human metapneumovirus and respiratory syncytial virus circulation, respectively, before the COVID-19 pandemic. No respiratory viral associations with Kawasaki disease were observed during the COVID-19 pandemic. Our large ecological analysis demonstrates novel spatiotemporal relationships between human metapneumovirus and respiratory syncytial virus circulation with Kawasaki disease. The disappearance of these associations in the COVID-19 pandemic may reflect the reduced circulation of non-SARS-CoV-2 viruses during this period, supporting the prepandemic associations identified in this study. The roles of human metapneumovirus and respiratory syncytial virus in Kawasaki disease etiology warrant further investigation.

Sections du résumé

Background UNASSIGNED
Kawasaki disease is an uncommon vasculitis affecting young children. Its etiology is not completely understood, although infections have been frequently postulated as the triggers. Respiratory viruses, specifically, have often been implicated as causative agents for Kawasaki disease presentations.
Objective UNASSIGNED
We aimed to conduct an ecological spatiotemporal analysis to determine whether Kawasaki disease incidence was related to community respiratory virus circulation in a shared region and population, and to describe viral associations before and during the COVID-19 pandemic.
Methods UNASSIGNED
We obtained independent statewide data sets of hospital admissions of Kawasaki disease and respiratory multiplex polymerase chain reaction tests performed at two large hospital networks in Victoria, Australia, from July 2011 to November 2021. We studied spatiotemporal relationships by negative binomial regression analysis of the monthly incidence of Kawasaki disease and the rate of positive respiratory polymerase chain reaction tests in different regions of Victoria. Peak viral seasons (95th percentile incidence) were compared to median viral circulation (50th percentile incidence) to calculate peak season increased rate ratios.
Results UNASSIGNED
While no seasonal trend in Kawasaki disease incidence was identified throughout the study period, we found a 1.52 (99% CI 1.27-1.82) and a 1.43 (99% CI 1.17-1.73) increased rate ratio of Kawasaki disease presentations in association with human metapneumovirus and respiratory syncytial virus circulation, respectively, before the COVID-19 pandemic. No respiratory viral associations with Kawasaki disease were observed during the COVID-19 pandemic.
Conclusions UNASSIGNED
Our large ecological analysis demonstrates novel spatiotemporal relationships between human metapneumovirus and respiratory syncytial virus circulation with Kawasaki disease. The disappearance of these associations in the COVID-19 pandemic may reflect the reduced circulation of non-SARS-CoV-2 viruses during this period, supporting the prepandemic associations identified in this study. The roles of human metapneumovirus and respiratory syncytial virus in Kawasaki disease etiology warrant further investigation.

Identifiants

pubmed: 39056286
pii: v10i1e49648
doi: 10.2196/49648
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e49648

Informations de copyright

© Rana Sawires, Hazel J Clothier, David Burgner, Michael Collingwood Fahey, Jim Buttery. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org).

Auteurs

Rana Sawires (R)

Department of Paediatrics, Monash University, Wellington Road, Clayton, 3800, 61 411717227, Australia.
Centre for Health Analytics, Murdoch Children's Research Institute, Parkville, Australia.

Hazel J Clothier (HJ)

Centre for Health Analytics, Murdoch Children's Research Institute, Parkville, Australia.
Surveillance of Adverse Events Following Vaccination in the Community, Murdoch Children's Research Institute, Parkville, Australia.
Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.

David Burgner (D)

Department of Paediatrics, Monash University, Wellington Road, Clayton, 3800, 61 411717227, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Australia.
Inflammatory Origins, Murdoch Children's Research Institute, Parkville, Australia.

Michael Collingwood Fahey (MC)

Department of Neurology, Monash Children's Hospital, Clayton, Australia.
Neurogenetics Department, Monash Paediatrics, Monash University, Clayton, Australia.

Jim Buttery (J)

Department of Paediatrics, Monash University, Wellington Road, Clayton, 3800, 61 411717227, Australia.
Centre for Health Analytics, Murdoch Children's Research Institute, Parkville, Australia.
Surveillance of Adverse Events Following Vaccination in the Community, Murdoch Children's Research Institute, Parkville, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH